University of Akron professor receives NSF grant for research that supports anti-cancer therapeutics

NewsGuard 100/100 Score

Dr. Adam W. Smith, assistant professor in the Department of Chemistry, has won a CAREER award from the National Science Foundation. The title of the award is "Lipid Regulation of Receptor Tyrosine Kinases" and provides $650,000 of funding for research. The project will use advanced fluorescence methods to measure lipid-protein interactions in biological membranes.

The goal is to develop a quantitative chemical model for the interface between plasma membrane lipids and a class of membrane proteins called receptor tyrosine kinases (RTKs). RTKs are integral membrane proteins that regulate cell growth and differentiation, and are targeted by a new class of anti-cancer therapeutics that will be greatly improved by this research.

This project also includes development of a 3D-printable, smartphone spectrometer (the SpecPhone) for implementation in university laboratory courses. The low cost and simplicity of the SpecPhone also make it accessible to K-12 students and citizens so that they can engage in real-world science problems. The objectives are to create new curriculum and teacher training workshops for K-12 STEM education, to participate in local Maker Faires, and to develop protocols for a transformative citizen science project in the Lake Erie watershed.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge